You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 121 No. 4, April 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE 66TH ANNUAL MEETING OF THE NEW ENGLAND SURGICAL SOCIETY, DIXVILLE NOTCH, NH, OCT 11-13, 1985
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (45)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Intraoperative Electron Beam Radiotherapy in the Treatment of Unresectable Rectal Cancer

Joel E. Tepper, MD; Alfred M. Cohen, MD; William C. Wood, MD; Stephen E. Hedberg, MD; Erica Orlow

Arch Surg. 1986;121(4):421-423.


Abstract

• We treated 29 patients who had primarily unresectable rectal cancer with an aggressive combined surgical and radiotherapeutic approach. Each patient received 5,040 rad of preoperative external beam radiation therapy. Eighteen patients responded adequately to allow resection of all macroscopic tumor; 11 patients underwent resection but had residual cancer in the pelvis. A single bolus of 1,000 to 2,000 rad of intraoperative electron beam radiation was given. Follow-up time ranged from three to 66 months, with a median of 43 months for living patients. The actuarial local control rate at 36 months for the entire group was 87%. In the group of 18 patients who underwent resection, the local control rate was 92%, with a three-year survival rate of 70%. Our results are considerably improved over our prior experience without intraoperative radiation therapy—a 57% local control rate and a 30% three-year survival rate.

(Arch Surg 1986;121:421-423)



Author Affiliations

From the Radiation Medicine Department (Dr Tepper and Ms Orlow) and the Surgical Oncology Unit (Drs Cohen, Wood, and Hedberg), Massachusetts General Hospital Cancer Center, and Harvard Medical School, Boston.


Footnotes

Accepted for publication Jan 7, 1986.

Deceased.

Read before the 66th Annual Meeting of the New England Surgical Society, Dixville Notch, NH, Oct 12, 1985.

Reprint requests to the Surgical Oncology Unit, Cox Building, Massachusetts General Hospital, Boston, MA 02114 (Dr Cohen).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Intraoperative Radiation Therapy and Hyperthermia: Morbidity and Mortality From This Combined Treatment Modality for Unresectable Intra-abdominal Carcinomas
Colacchio et al.
Arch Surg 1990;125:370-375.
ABSTRACT  

Management of Recurrent Pelvic Tumors
Benotti et al.
Arch Surg 1987;122:457-460.
ABSTRACT  

The Archives of Surgery, New England Surgical Society, and JAMA
Baue
JAMA 1986;255:2210-2211.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.